Z. Motovska

Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial.

C. Macintyre, O. Hlinomaz, S. Jensen, 2022, American heart journal.

Impact of admitting department on the management of acute coronary syndrome after an out of hospital cardiac arrest.

Jirí Jarkovský, J. Knot, P. Waldauf, 2022, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials

M. Aschermann, O. Hlinomaz, P. Kala, 2023, Frontiers in Cardiovascular Medicine.

Influenza vaccination in failing hearts.

T. Geisler, Z. Motovska, 2022, The Lancet. Global health.

Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations

T. Geisler, Y. Jeong, Sang Yeub Lee, 2023, Frontiers in Cardiovascular Medicine.

Outcomes Of Patients With Myocardial Infarction And Cardiogenic Shock Treated With Culprit Vessel-Only Versus Multivessel Primary Pci.

J. Přeček, J. Mrózek, O. Hlinomaz, 2023, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Optimal timing of influenza vaccination among patients with acute myocardial infarction - Findings from the IAMI trial.

O. Hlinomaz, A. Erglis, D. Erlinge, 2023, Vaccine.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

J. Mrózek, O. Hlinomaz, P. Kala, 2023, European Journal of Internal Medicine.